Literature DB >> 7387968

Intraocular pressure response to corticosteroids in children.

B Z Biedner, R David, A Grudsky, U Sachs.   

Abstract

A total of 44 children who suffered from vernal conjunctivitis were treated with topical dexamethasone 0.1% 4 times daily for 6 weeks and tested for their intraocular pressure. There was a statistically significant difference (P less than 0.01) between the responders in our group of children and a group of normal adults reported on by Armaly in 1965.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7387968      PMCID： PMC1043722          DOI： 10.1136/bjo.64.6.430

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  4 in total

1.  STATISTICAL ATTRIBUTES OF THE STEROID HYPERTENSIVE RESPONSE IN THE CLINICALLY NORMAL EYE. I. THE DEMONSTRATION OF THREE LEVELS OF RESPONSE.

Authors:  M F ARMALY
Journal:  Invest Ophthalmol       Date:  1965-04

2.  Epidemiology of simple glaucoma and ocular hypertension.

Authors:  P A Graham
Journal:  Br J Ophthalmol       Date:  1972-03       Impact factor: 4.638

3.  Inheritance of dexamethasone hypertension and glaucoma.

Authors:  M F Armaly
Journal:  Arch Ophthalmol       Date:  1967-06

4.  Corticosteroid glaucoma.

Authors:  J François
Journal:  Ann Ophthalmol       Date:  1977-09
  4 in total
  10 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

3.  Ocular hypertensive response to topical dexamethasone ointment in children.

Authors:  Yoon Jung Lee; Chan Yi Park; Kyung In Woo
Journal:  Korean J Ophthalmol       Date:  2006-09

4.  The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases.

Authors:  Li Li; Chunxia Peng; Honggai Yan; Xiaohua Tan; Jifeng Yu; Tianwei Liang; Wei Shi
Journal:  Int Ophthalmol       Date:  2022-01-19       Impact factor: 2.029

Review 5.  Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.

Authors:  John D Sheppard; Timothy L Comstock; Megan E Cavet
Journal:  Adv Ther       Date:  2016-03-17       Impact factor: 3.845

6.  Outcome of Primary Nonpenetrating Deep Sclerectomy in Patients with Steroid-Induced Glaucoma.

Authors:  Abdelhamid Elhofi; Hany Ahmed Helaly
Journal:  J Ophthalmol       Date:  2018-04-04       Impact factor: 1.909

7.  Evaluation and management of systemic corticosteroids-induced ocular hypertension in children with non-Hodgkin lymphoma.

Authors:  Yitian Chang; YuTong Zhang; Zhihua Cui; Xianmei Jin; Yufei Zhao; Lingling Liang; Jian Chang
Journal:  Front Pediatr       Date:  2022-08-12       Impact factor: 3.569

8.  Intraocular Pressure Elevation Following the Use of Topical Dexamethasone Ointment After Squint Surgery.

Authors:  Mary O Ugalahi; Folahan A Ibukun; Bolutife A Olusanya; Aderonke M Baiyeroju
Journal:  J West Afr Coll Surg       Date:  2022-08-23

9.  Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis.

Authors:  Marcus Ang; Seng-Ei Ti; Raymond Loh; Sonal Farzavandi; Rongli Zhang; Donald Tan; Cordelia Chan
Journal:  Clin Ophthalmol       Date:  2012-08-03

10.  Severe ocular hypertension secondary to systemic corticosteroid treatment in a child with nephrotic syndrome.

Authors:  Pedro Nuno Brito; Sérgio Estrela Silva; José Silva Cotta; Fernando Falcão-Reis
Journal:  Clin Ophthalmol       Date:  2012-10-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.